4 recruiting, 3 not yet recruiting, 2 active not recruiting, 2 completed. 4 Not applicable, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow HBV Infection: new trials by email Literature Review of HBV Infection trials Research Report on HBV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission" HBsAg RDT Women, Treatment by TDF if HBcrAg RDT positive, Treatment by TDF - HBV Infection, Pregnancy | Not applicable | Recruiting | ANRS, Emerging Infectious Diseases | 3200 | 2026-08-10 | 2026-10-08 |
| Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 in the Treatment of Chronic Hepatitis B TVAX-028, Adjuvant - HBV Infection | Phase 1 | Not yet recruiting | Grand Theravac Life Sciences (Nanjing) Co., Ltd. | 32 | 2026-05-31 | 2026-06-29 |
| "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort" Blood sampling, Umbilical cord blood sampling, Survey using a questionnaire - HIV Infection, HBV Infection | Not yet recruiting | ANRS, Emerging Infectious Diseases | 5160 | 2026-02-01 | 2026-02-17 | |
| A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B HECN30227 injection(SAD), Placebo(MAD), Placebo(SAD) - HBV Infection | Phase 1 | Recruiting | Sunshine Lake Pharma Co., Ltd. | 78 | 2025-12-02 | 2026-08-18 |
| Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus NA(s)+HT-102+FD-001 - HBV Infection, HCC - Hepatocellular Carcinoma | Not applicable | Not yet recruiting | Shanghai Zhongshan Hospital | 12 | 2025-08-01 | 2025-07-28 |
| STOP HCC-GAAD-APAC-Thailand GAAD score - Hepatecellular Carcinoma, Cirrhosis | Not applicable | Enrolling by invitation | Mahidol University | 2100 | 2025-02-02 | 2026-01-06 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients TVAX-008, Placebo - HBV Infection | Phase 2 | Active not recruiting | Grand Theravac Life Sciences (Nanjing) Co., Ltd. | 48 | 2025-01-22 | 2025-09-18 |
| Immune Dynamics in the Natural History of Chronic HBV Infection Venipuncture - HBV (Hepatitis B Virus), HBV Infection | Recruiting | Nanfang Hospital, Southern Medical University | 5000 | 2024-02-01 | 2025-09-30 | |
| Population-wide Research for HBV-related Liver Diseases in Maoming City Rapid tests for HBsAg - HBV Infection, Chronic Hepatitis B | Unknown | Nanfang Hospital, Southern Medical University | 3700000 | 2024-02-01 | 2024-01-09 | |
| Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease Collection of Preoperative Peripheral Blood, Collection of Discarded Liver Tissue During Surgery - Liver Neoplasm, HBV Infection | Recruiting | Nanfang Hospital, Southern Medical University | 240 | 2023-03-01 | 2026-04-14 | |
| The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT. Tenofovir Amibufenamide（TMF） - HBV Infection, Chronic Hepatitis b | Not applicable | Active not recruiting | Ruijin Hospital | 200 | 2022-06-08 | 2025-11-17 |
| Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals HDV Infection, HBV Infection | Completed | Assiut University | 186 | 2015-11-01 | 2019-07-30 | |
| The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication HBV Infection | Completed | Lu KZ | 30 | 2014-01-01 | 2015-01-28 |
Hepatitis B, Chronic (3) · Fibrosis (2) · Hepatitis B (2) · Arbovirus Infections (1) · Carcinoma, Hepatocellular (1) · HIV Infections (1) · Hepatitis (1) · Hepatitis C (1) · Liver Cirrhosis (1) · Liver Neoplasms (1) · Neurocognitive Disorders (1)
Digestive System Diseases (7) · Liver Diseases (7) · Blood-Borne Infections (5) · Communicable Diseases (5) · Hepatitis, Viral, Human (5) · Infections (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Virus Diseases (5) · DNA Virus Infections (4) · Hepadnaviridae Infections (4) · Hepatitis (4) · Chronic Disease (3) · Disease Attributes (3) · Hepatitis, Chronic (3)
Adjuvants, Pharmaceutic (1) · Blood Specimen Collection (1) · Cordocentesis (1) · Hepatitis B Surface Antigens (1) · Phlebotomy (1) · mycophenolic adenine dinucleotide (1)
Nanfang Hospital, Southern Medical University (3) · ANRS, Emerging Infectious Diseases (2) · Grand Theravac Life Sciences (Nanjing) Co., Ltd. (2) · Assiut University (1) · Lu KZ (1) · Mahidol University (1) · Ruijin Hospital (1) · Shanghai Zhongshan Hospital (1) · Sunshine Lake Pharma Co., Ltd. (1)
China (6) · France (1) · Thailand (1) · Vietnam (1)
Amal A Mahmoud, MD, Assistanr Professor (1) · Li Liu (1) · Lu KZ, PhD (1) · Tawesak Tanwandee (1) · Tawesak Tanwandee, MD (1)
PMID 28620797, PMID 29425931, PMID 29628281, PMID 31712073, PMID 36386418, PMID 37199193, PMID 40937079